Skip to search formSkip to main contentSkip to account menu

R-2HMP

Known as: R-N-2-heptyl-N-methylpropargylamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases.
Review
2001
Review
2001
Anti-apoptotic actions of R-2HMP in cerebellar granule cells : changes of mitochondrial membrane potential and sub-cellular GAPDH protein
(R)-N-(2-hepty1)-N-methyIpropargy1amine (R-2HMP) has been shown to reduce neuronal death through an action at the same site as R… 
2001
2001
Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
(R)-N-(2-Heptyl)-N-methyl-propargylamine (R-2HMP) and (R)-N-(2-heptyl)-propargylamine (R-2HPA) are analogs of R-deprenyl. R… 
2000
2000
Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent.
(R)-N-(2-Heptyl)-N-methylpropargylamine (R-2HMP) is a monoamine oxidase inhibitor and putative antiapoptotic agent analogous to… 
Review
2000
Review
2000
Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of (-)deprenyl.
(-)Deprenyl has been reported to prolong the life span of different animal species. Further, the drug effectively increases… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)